FindMyRecallSubscribe
Class I: serious health riskTerminated

Hua Da Trading, Inc. dba Wefun WEFUN Capsules 825 mg Recall

WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY…

Hua Da Trading, Inc. dba Wefun Inc. · Brooklyn, NY

Risk level
Class I
Reported by FDA
Sep 20, 2023
Recall ID
D-1180-2023
Check your lot numberHow we source this data

Summary

Hua Da Trading, Inc. dba Wefun recalled WEFUN Capsules 825 mg starting Aug 25, 2023. The FDA classified it as Class I (serious health risk) and published enforcement report D-1180-2023 on Sep 20, 2023. Reason: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug. Status: Terminated.

Why it was recalled

Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.

Product description

WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY 11204 www.eshoponlineusa.com Bar Code X00358V0O5

Lot numbers, UPCs & expiration codes

Lot # #18520168, Exp. date 09/30/2026 .

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1180-2023
Classification
Class I
Status
Terminated
Recall initiated
Aug 25, 2023
FDA report date
Sep 20, 2023
Quantity
300 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Hua Da Trading, Inc. dba Wefun Inc.

Original FDA data

Every field from FDA enforcement report D-1180-2023, exactly as published.

Show all FDA fields
City
Brooklyn
State
NY
Status
Terminated
Country
United States
Event ID
92979
Address
6306 20th Ave
Code information
Lot # #18520168, Exp. date 09/30/2026 .
Postal code
11204-3049
Report date
Sep 20, 2023
Product type
Drugs
Recall number
D-1180-2023
Classification
Class I
Recalling firm
Hua Da Trading, Inc. dba Wefun Inc.
Product quantity
300 cartons
Termination date
Apr 30, 2026
Reason for recall
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Voluntary / mandated
Voluntary: Firm initiated
Product description
WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY 11204 www.eshoponlineusa.com Bar Code X00358V0O5
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Aug 25, 2023
Initial firm notification
Press Release
Center classification date
Sep 29, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1180-2023, published Sep 20, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls